TABLE 5.
Genital or breast stage(calcium group, placebo group)2 |
Pubic hair stage(calcium group, placebo group)2 |
||||||||||
Time point | n(calcium group, placebo group ) | 1 | 2 | 3 | 4 | 5 | 1 | 2 | 3 | 4 | 5 |
% of participants | % of participants | ||||||||||
Boys | |||||||||||
Y1 | 40, 40 | 90, 80 | 10, 20 | 0, 0 | 0, 0 | 0, 0 | 100, 98 | 0, 3 | 0, 0 | 0, 0 | 0, 0 |
Y2 | 40, 40 | 70, 68 | 25, 23 | 5, 10 | 0, 0 | 0, 0 | 95, 95 | 5, 1 | 5, 1 | 0, 0 | 0, 0 |
Y3 | 40, 40 | 53, 58 | 35, 23 | 10, 18 | 3, 3 | 0, 0 | 83, 85 | 15, 13 | 0, 0 | 0, 0 | 0, 0 |
Y4 | 40, 40 | 53, 60 | 25, 25 | 13, 8 | 10, 8 | 0, 0 | 60, 65 | 30, 23 | 5, 5 | 8, 8 | 0, 0 |
Y6 | 36, 37 | 8, 14 | 31, 32 | 33, 22 | 19, 19 | 8, 14 | 22, 30 | 25, 24 | 19, 19 | 28, 19 | 7, 8 |
Girls | |||||||||||
Y1 | 40, 40 | 80, 93 | 15, 8 | 5, 0 | 0, 0 | 0, 0 | 80, 85 | 15, 13 | 5, 3 | 0, 0 | 0, 0 |
Y2 | 40, 39 | 73, 85 | 8, 10 | 15, 3 | 5, 3 | 0, 0 | 70, 82 | 13, 13 | 13, 3 | 5, 3 | 0, 0 |
Y3 | 40, 40 | 48, 65 | 25, 15 | 13, 18 | 15, 3 | 0, 0 | 63, 75 | 15, 10 | 13, 10 | 8, 5 | 3, 0 |
Y4 | 38, 40 | 21, 25 | 37, 38 | 16, 18 | 13, 15 | 13, 5 | 49, 47 | 22, 32 | 16, 13 | 14, 8 | 0, 0 |
Y6 | 37, 38 | 6, 0 | 6, 5 | 8, 16 | 53, 50 | 28, 29 | 14, 0 | 6, 16 | 28, 41 | 36, 30 | 17, 14 |
Y8 | 38, 33 | 0, 0 | 0, 0 | 11, 6 | 29, 24 | 58, 70 | 0, 0 | 6, 0 | 6, 12 | 30, 35 | 52, 54 |
Y1, baseline; Y2–8, the year of follow-up relative to Y1.
The data are the percentage of participants assessed in the calcium and placebo groups in each Tanner stage.